Concept:
Grapefruit juice contains bio-active organic compounds, including furanocoumarins (such as bergamottin and dihydroxybergamottin) and flavonoids (such as naringin). These compounds act as potent, mechanism-based (irreversible) inhibitors of the CYP3A4 enzyme, a major member of the Cytochrome P450 enzyme family located in the intestinal wall and liver.
Step 1: Determine the mechanism of interaction.
When a patient consumes grapefruit juice along with drugs metabolized by CYP3A4 (such as simvastatin, amlodipine, or cyclosporine), the inhibition of intestinal CYP3A4 prevents presystemic first-pass metabolism. This leads to significantly increased bio-availability and elevated plasma concentrations of the drug, which can cause toxicity. Thus, the correct option is CYP450 inhibition.